Zynex Inc (ZYXI) - Total Liabilities
Based on the latest financial reports, Zynex Inc (ZYXI) has total liabilities worth $86.69 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ZYXI cash flow metrics to assess how effectively this company generates cash.
Zynex Inc - Total Liabilities Trend (1999–2024)
This chart illustrates how Zynex Inc's total liabilities have evolved over time, based on quarterly financial data. Check Zynex Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
Zynex Inc Competitors by Total Liabilities
The table below lists competitors of Zynex Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Link Bilgisayar Sistemleri Yazilimi ve Donanimi Sanayi ve Ticaret AS
IS:LINK
|
Turkey | TL497.79 Million |
|
CVC Income & Growth Limited
LSE:CVCG
|
UK | GBX316.86K |
|
Tesoro Minerals Corp.
V:TES
|
Canada | CA$33.21K |
|
Flexituff Ventures International Limited
NSE:FLEXITUFF
|
India | Rs4.67 Billion |
|
Redstone Resources Ltd
AU:RDS
|
Australia | AU$1.14 Million |
|
Awilco Drilling PLC
OL:AWDR
|
Norway | Nkr8.90 Million |
|
Adeunis
PA:ALARF
|
France | €4.63 Million |
Liability Composition Analysis (1999–2024)
This chart breaks down Zynex Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ZYXI stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.47 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.10 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.91 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zynex Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zynex Inc (1999–2024)
The table below shows the annual total liabilities of Zynex Inc from 1999 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $86.37 Million | -4.85% |
| 2023-12-31 | $90.78 Million | +68.13% |
| 2022-12-31 | $53.99 Million | -9.03% |
| 2021-12-31 | $59.35 Million | +241.71% |
| 2020-12-31 | $17.37 Million | +101.39% |
| 2019-12-31 | $8.62 Million | +25.24% |
| 2018-12-31 | $6.89 Million | +71.00% |
| 2017-12-31 | $4.03 Million | -48.98% |
| 2016-12-31 | $7.89 Million | +1.62% |
| 2015-12-31 | $7.77 Million | -7.33% |
| 2014-12-31 | $8.38 Million | -32.26% |
| 2013-12-31 | $12.37 Million | -10.69% |
| 2012-12-31 | $13.85 Million | +18.97% |
| 2011-12-31 | $11.64 Million | +54.87% |
| 2010-12-31 | $7.52 Million | +69.21% |
| 2009-12-31 | $4.44 Million | -26.06% |
| 2008-12-31 | $6.01 Million | +68.93% |
| 2007-12-31 | $3.56 Million | +140.24% |
| 2006-12-31 | $1.48 Million | +63.79% |
| 2005-12-31 | $904.13K | +54.10% |
| 2004-12-31 | $586.71K | -34.16% |
| 2003-12-31 | $891.11K | -7.29% |
| 2002-12-31 | $961.22K | +1.34% |
| 2001-12-31 | $948.54K | +27.97% |
| 2000-12-31 | $741.21K | -607647.54% |
| 1999-12-31 | $-122.00 | -- |
About Zynex Inc
Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) dev… Read more